Trulieve Cannabis Corp. (TRLV) stock
TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3010% below fair value
$10.90−0.25 (-2.24%)
Close on Nov 13, 2026Market cap $2.10BP/E –Yield –
Trulieve Cannabis ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Trulieve Cannabis's ebitda for the twelve months ending Sep 30, 2026 was -$174.42M, down 170.8% year over year. For fiscal 2025 it was $261.13M, up 24.0% from the year before. The highest annual figure on record is $261.13M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $261.13M | +24.0% |
| FY2024 | Dec 31, 2024 | $210.59M | – |
| FY2023 | Dec 31, 2023 | -$111.79M | -167.1% |
| FY2022 | Dec 31, 2022 | $166.55M | -33.3% |
| FY2021 | Dec 31, 2021 | $249.84M | +8.2% |
| FY2020 | Dec 31, 2020 | $230.90M | +95.1% |
| FY2019 | Dec 31, 2019 | $118.35M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $60.19M | -16.0% |
| Q2 FY2026 | Jun 30, 2026 | -$344.80M | -520.2% |
| Q1 FY2026 | Mar 31, 2026 | $65.47M | +4.5% |
| Q4 FY2025 | Dec 31, 2025 | $44.72M | +49.3% |
| Q3 FY2025 | Sep 30, 2025 | $71.69M | +147.6% |
| Q2 FY2025 | Jun 30, 2025 | $82.06M | +5.4% |
| Q1 FY2025 | Mar 31, 2025 | $62.65M | -15.2% |
| Q4 FY2024 | Dec 31, 2024 | $29.95M | -46.9% |
| Q3 FY2024 | Sep 30, 2024 | $28.95M | -42.4% |
| Q2 FY2024 | Jun 30, 2024 | $77.83M | – |
| Q1 FY2024 | Mar 31, 2024 | $73.86M | +57.9% |
| Q4 FY2023 | Dec 31, 2023 | $56.38M | +61.2% |
| Q3 FY2023 | Sep 30, 2023 | $50.30M | +2258.3% |
| Q2 FY2023 | Jun 30, 2023 | -$265.24M | -474.4% |
| Q1 FY2023 | Mar 31, 2023 | $46.77M | -18.8% |
| Q4 FY2022 | Dec 31, 2022 | $34.97M | +135.0% |
| Q3 FY2022 | Sep 30, 2022 | $2.13M | -97.1% |
| Q2 FY2022 | Jun 30, 2022 | $70.84M | -14.6% |
| Q1 FY2022 | Mar 31, 2022 | $57.61M | -26.1% |
| Q4 FY2021 | Dec 31, 2021 | $14.88M | -78.1% |
| Q3 FY2021 | Sep 30, 2021 | $74.00M | +17.9% |
| Q2 FY2021 | Jun 30, 2021 | $82.97M | +49.3% |
| Q1 FY2021 | Mar 31, 2021 | $78.00M | +74.5% |
| Q4 FY2020 | Dec 31, 2020 | $67.82M | – |
| Q3 FY2020 | Sep 30, 2020 | $62.79M | – |
| Q2 FY2020 | Jun 30, 2020 | $55.59M | – |
| Q1 FY2020 | Mar 31, 2020 | $44.71M | – |
See a number that looks wrong?